Related references
Note: Only part of the references are listed.Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection
Lander Foquet et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
Martha Sedegah et al.
PLOS ONE (2014)
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
Philip Bejon et al.
LANCET INFECTIOUS DISEASES (2013)
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
Martha Sedegah et al.
MALARIA JOURNAL (2013)
Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
Ally Olotu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P-falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
Ilin Chuang et al.
PLOS ONE (2013)
Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities
Ashley J. Birkett et al.
VACCINE (2013)
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J. Ewer et al.
NATURE COMMUNICATIONS (2013)
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Cindy Tamminga et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
Matthew G. Cottingham et al.
BIOTECHNOLOGY AND BIOENGINEERING (2012)
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
Geraldine A. O'Hara et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
ChAd63-MVA-vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
Susanne H. Sheehy et al.
MOLECULAR THERAPY (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
Susanne H. Sheehy et al.
PLOS ONE (2012)
A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E
Francis M. Ndungu et al.
PLOS ONE (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
Susanne H. Sheehy et al.
MOLECULAR THERAPY (2011)
Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D
Selidji T. Agnandji et al.
PLOS ONE (2011)
Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
J. E. Epstein et al.
SCIENCE (2011)
Protective immunity to pre-erythrocytic stage malaria
Robert J. Schwenk et al.
TRENDS IN PARASITOLOGY (2011)
Experimental human challenge infections can accelerate clinical malaria vaccine development
Robert W. Sauerwein et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses
Arturo Reyes-Sandoval et al.
INFECTION AND IMMUNITY (2010)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
Fiona M. Thompson et al.
PLOS ONE (2008)
Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite
Agam Prasad Singh et al.
CELL (2007)
Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes:: An update
Judith E. Epstein et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and immunogenicity of the malaria candidate vaccines FP9CS and MVA CS in adult Gambian men
E. B. Imoukhuede et al.
VACCINE (2006)
A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S. J. Dunachie et al.
INFECTION AND IMMUNITY (2006)
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein
M Walther et al.
INFECTION AND IMMUNITY (2006)
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya
P Bejon et al.
CLINICAL INFECTIOUS DISEASES (2006)
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites
P Bejon et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion
A Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif
O Bruna-Romero et al.
VACCINE (2004)
Share Paper
